Acutus Medical Inc.’s AcQMap multi-electrode electrophysiology mapping catheter has the potential to fundamentally change how arrhythmias are understood and treated, according to Andrew Grace, University of Cambridge, one of the investigators of two studies demonstrating the potential of AcQMap to identify non-pulmonary vein targets for atrial fibrillation ablation.
Acutus Is Trying To Fundamentally Change Understanding Of Arrhythmia With AcQMap
New trial results show Acutus Medical's AcQMap platform has the ability to classify conduction patterns and localized non-pulmonary-vein therapeutic targets for ablation to treat atrial fibrillation, which could have implications for both treatment of atrial fibrillation and understanding the genetic markers for this common arrhythmia, according to the authors.
